The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals February 23, 2017 Meet the 4 VC-Backed Biotech Startups That Just Landed Space in Kendall Square September 5, 2017 Bayer's Job Cuts at Mission Bay Campus Leaves Room for New Bay Area Startups February 23, 2017
Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals February 23, 2017
